Target Therapies for NASH/NAFLD: From the Molecular Aspect to the Pharmacological and Surgical Alternatives

Non-alcoholic fatty liver disease represents an increasing cause of chronic hepatic disease in recent years. This condition usually arises in patients with multiple comorbidities, the so-called metabolic syndrome. The therapeutic options are multiple, ranging from lifestyle modifications, pharmacolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Finotti, Michele, Romano, Maurizio, Auricchio, Pasquale, Scopelliti, Michele, Brizzolari, Marco, Grossi, Ugo, Piccino, Marco, Benvenuti, Stefano, Morana, Giovanni, Cillo, Umberto, Zanus, Giacomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229090/
https://www.ncbi.nlm.nih.gov/pubmed/34199535
http://dx.doi.org/10.3390/jpm11060499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229090/
https://www.ncbi.nlm.nih.gov/pubmed/34199535
http://dx.doi.org/10.3390/jpm11060499

Ejemplares similares